Immunoconjugates with an intracellularly-cleavable linkage
US7999083B2 · kind B2 · utility
113Cited by
10References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 2, 2009 |
| Grant date | Aug 16, 2011 |
| Priority date | — |
| Expiry date | Dec 2, 2029 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to therapeutic conjugates with improved ability to target various diseased cells containing a targeting moiety (such as an antibody or antibody fragment), a linker and a therapeutic moiety, and further relates to processes for making and using the conjugates.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.